{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:41:02Z","timestamp":1768560062473,"version":"3.49.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.1182\/blood.2025030987","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T16:32:07Z","timestamp":1768494727000},"page":"226-227","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["miR-aculous effects for hemophilic arthropathy"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-964X","authenticated-orcid":false,"given":"Laurent O.","family":"Mosnier","sequence":"first","affiliation":[{"name":"The Scripps Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"3","key":"2026011511320354200_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2024027143","article-title":"Factor VIIa\u2013released extracellular vesicles attenuate joint bleed\u2013induced hemophilic arthropathy","volume":"147","author":"Kavadipula","year":"2026","journal-title":"Blood"},{"issue":"1","key":"2026011511320354200_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminhematol.2015.10.005","article-title":"Advances and challenges in hemophilic arthropathy","volume":"53","author":"Wyseure","year":"2016","journal-title":"Semin Hematol"},{"key":"2026011511320354200_bib3","doi-asserted-by":"crossref","first-page":"101304","DOI":"10.1016\/j.blre.2025.101304","article-title":"Unmet needs in hemophilic arthropathy","author":"Dargaud","year":"2025","journal-title":"Blood Rev"},{"issue":"8","key":"2026011511320354200_bib4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.jtha.2024.04.006","article-title":"RNA therapeutics to control fibrinolysis: review on applications in biology and medicine","volume":"22","author":"Ferraresso","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"21","key":"2026011511320354200_bib5","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1182\/blood-2017-10-813527","article-title":"Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1","volume":"131","author":"Kondreddy","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2026011511320354200_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","article-title":"Activated protein C, protease activated receptor 1, and neuroprotection","volume":"132","author":"Griffin","year":"2018","journal-title":"Blood"},{"issue":"16","key":"2026011511320354200_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.2023023518","article-title":"A potential mechanism for the cytoprotective effects of activated protein C-released endothelial extracellular vesicles","volume":"143","author":"Das","year":"2024","journal-title":"Blood"},{"issue":"5","key":"2026011511320354200_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/ATVBAHA.120.314244","article-title":"FVIIa (factor VIIa) induces biased cytoprotective signaling in mice through the cleavage of PAR (protease-activated receptor)-1 at canonical Arg41 (Arginine41) site","volume":"40","author":"Kondreddy","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2026011511320354200_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood-2017-10-810895","article-title":"PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke","volume":"131","author":"Sinha","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2026011511320354200_bib10","doi-asserted-by":"crossref","first-page":"100037","DOI":"10.1016\/j.bvth.2024.100037","article-title":"In vivo neuroprotection in ischemic stroke by activated protein C requires \u03b2-arrestin 2","volume":"2","author":"Xiang","year":"2025","journal-title":"Blood Vessel Thromb Hemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/3\/226\/2498131\/blood_bld-2025-030987-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/3\/226\/2498131\/blood_bld-2025-030987-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T16:32:08Z","timestamp":1768494728000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/3\/226\/565870\/miR-aculous-effects-for-hemophilic-arthropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025030987","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,15]]},"published":{"date-parts":[[2026,1,15]]}}}